Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?

被引:73
作者
Castera, Laurent [1 ]
Denis, Jacques
Babany, Gerard
Roudot-Thoraval, Francoise
机构
[1] Ctr Hosp Univ Bordeaux, Serv Hepatogastroenterol, Bordeaux, France
[2] Ctr Hosp Sud Francilien, Serv HepatoGastroenterol, Corbeil Essonnes, France
[3] Hop Henri Mondor, APHP, Dept Sante Publ, F-94010 Creteil, France
关键词
D O I
10.1016/j.jhep.2006.12.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:528 / +
页数:2
相关论文
共 7 条
[2]  
[Anonymous], 1999, J Hepatol, V31 Suppl 1, P3
[3]   Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C [J].
Castéra, L ;
Vergniol, J ;
Foucher, J ;
Le Bail, B ;
Chanteloup, E ;
Haaser, M ;
Darriet, M ;
Couzigou, P ;
De Lédinghen, V .
GASTROENTEROLOGY, 2005, 128 (02) :343-350
[4]  
Castera Laurent, 2005, MedGenMed, V7, P39
[5]  
Poynard Thierry, 2004, Comp Hepatol, V3, P8, DOI 10.1186/1476-5926-3-8
[6]   Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C [J].
Sebastiani, G ;
Vario, A ;
Guido, M ;
Noventa, F ;
Plebani, M ;
Pistis, R ;
Ferrari, A ;
Alberti, A .
JOURNAL OF HEPATOLOGY, 2006, 44 (04) :686-693
[7]   Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy [J].
Sebastiani, Giada ;
Alberti, Alfredo .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (23) :3682-3694